Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HSD17B6 |
| Upstream (Parents) |
|---|
| (<<) CFHR2 → HSD17B6 |
| (<<) BHMT2 → HSD17B6 |
| (<<) CDO1 → HSD17B6 |
| Downstream (Children) |
|---|
| HSD17B6 → BHMT2 (>>) |
| HSD17B6 → CDO1 (>>) |
| HSD17B6 → CES1 (>>) |
| HSD17B6 → ACSM5 (>>) |
| HSD17B6 → GAMT (>>) |
| HSD17B6 → SNAPC4 (>>) |
| HSD17B6 → CRYAA (>>) |
| HSD17B6 → COL4A4 (>>) |
